It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Inter-organelle contact and communication between mitochondria and sarco/endoplasmic reticulum (SR/ER) maintain cellular homeostasis and are profoundly disturbed during tissue ischemia. We tested the hypothesis that the formin Diaphanous-1 (DIAPH1), which regulates actin dynamics, signal transduction and metabolic functions, contributes to these processes. We demonstrate that DIAPH1 interacts directly with Mitofusin-2 (MFN2) to shorten mitochondria-SR/ER distance, thereby enhancing mitochondria-ER contact in cells including cardiomyocytes, endothelial cells and macrophages. Solution structure studies affirm the interaction between the Diaphanous Inhibitory Domain and the cytosolic GTPase domain of MFN2. In male rodent and human cardiomyocytes, DIAPH1-MFN2 interaction regulates mitochondrial turnover, mitophagy, and oxidative stress. Introduction of synthetic linker construct, which shorten the mitochondria-SR/ER distance, mitigated the molecular and functional benefits of DIAPH1 silencing in ischemia. This work establishes fundamental roles for DIAPH1-MFN2 interaction in the regulation of mitochondria-SR/ER contact networks. We propose that targeting pathways that regulate DIAPH1-MFN2 interactions may facilitate recovery from tissue ischemia.
Proximity between mitochondria and endoplasmic reticulum regulates mitochondria fitness and is adversely affected by tissue ischemia. This work reveals that Diaphanous1-Mitofusin2 interaction regulates this proximity and impairs recovery in ischemia.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 NYU Grossman School of Medicine, Diabetes Research Program, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)
2 University of Albany, State University of New York, Department of Chemistry, Albany, USA (GRID:grid.265850.c) (ISNI:0000 0001 2151 7947)
3 NYU Grossman School of Medicine, Department of Medicine, Leon H. Charney Division of Cardiology, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)
4 NYU Grossman School of Medicine, Department of Pathology, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)
5 NYU Grossman School of Medicine, Department of Population Health, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)
6 Smidt Heart Institute, Cedars-Sinai Medical Center, Department of Cardiology, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
7 Smidt Heart Institute, Cedars-Sinai Medical Center, Department of Biomedical Sciences, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)